Pavel Osmančík

Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation

Pavel Osmančík, Dalibor Heřman, Petr Neužil et al. · Journal of the American College of Cardiology · 2020 · 580 citations

Thrombosis, Cardiovascular Disease, Coagulopathy +8

Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

Emmanuel Ekanem, Petr Neužil, Tobias Reichlin et al. · Nature Medicine · 2024 · 308 citations · Full text

4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation

Pavel Osmančík, Dalibor Heřman, Petr Neužil et al. · Journal of the American College of Cardiology · 2021 · 254 citations

Thrombosis, Cardiovascular Disease, Coagulopathy +8

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens et al. · Journal of the American Heart Association · 2016 · 196 citations · Full text

Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study

Petr Budera, Z. Straka, Pavel Osmančík et al. · European Heart Journal · 2012 · 150 citations · Full text